FYR Diagnostics

FYR Diagnostics is revolutionizing the ability to dynamically observe diseases and treatment responses to generate better biomarkers, trials, drugs, and outcomes. FYR’s EV-Omics (EVO) platform leverages its proprietary SPARC™ technology to enrich extracellular vesicles from diseased cells and assess cellular proteins and nucleic acids through peripheral blood samples alone. EVO utilizes AI-supported multi-omics insights to unravel the complexity of disease mechanisms, informing potential diagnostic and therapeutic strategies. The unparalleled view provided by FYR’s multi-omics approach has the potential to transform personalized patient care, from screening to treatment selection and monitoring.